Skip to content

US · TRLV · MEDICAL - PHARMACEUTICALS

Trulieve Cannabis Corp. (TRLV) intrinsic value and stock valuation

$8.68as of 2026-11-21 · Mkt cap 1.49B

Data updated · price as of 2026-11-21

IC valuationIntrinsic value, upside vs price and the fair-value band are available to Pro members.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

Trulieve Cannabis Corp. DCF and intrinsic value

InvestorsCraft values TRLV with the Chepakovich two-stage DCF model. How the model works · Run your own DCF prefilled from TRLV’s statements →

Trulieve Cannabis Corp. Graham Number

The Graham Number is not defined for negative earnings or book value. Guide · Calculator →

Healthcare · Medical - Pharmaceuticals Tallahassee, FL 32312 trulieve.com

How the business is doing

Fiscal 2025–2025, USD

Revenue
$1.18B
20252025
Net income
-$-116.38M
20252025
Free cash flow
$212.3M
20252025
Total equity
$1.14B
20252025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Financials

Statements by fiscal year

Fiscal 2025–2025, USD
2025
Revenue$1.18B
Operating income$148.3M
Net income-$-116.38M
EPSd-$-608.36K
Operating cash flow$272.8M
Capital expenditure-$-60.51M
Free cash flow$212.3M
Total assets$2.7B
Total debt$563.6M
Net debt$308.1M
Total equity$1.14B
Cash and short-term investments$255.5M
Income statement
2025
Revenue$1.18B
Cost of revenue$470M
Gross profit$711.2M
Research and development expenses$0.00
Selling, general and administrative expenses$445.2M
Other expenses$117.6M
Operating expenses$562.9M
Cost and expenses$1.03B
Interest income$14.5M
Interest expense$63.5M
Depreciation and amortization$173.4M
Ebitda$328.3M
Operating income$148.3M
Total other income/expenses, net-$-56.85M
Income before tax$91.5M
Income tax expense$208.1M
Net income-$-116.38M
Weighted average shares outstanding$191.3M
Weighted average diluted shares outstanding$191.3M
Balance sheet
2025
Cash and short-term investments$255.5M
Net receivables$20.2M
Inventory$242.3M
Total current assets$562.7M
Property, plant and equipment, net$838.7M
Goodwill and intangible assets$1.28B
Long-term investments$0.00
Total non-current assets$2.13B
Total assets$2.7B
Accounts payable$26.8M
Short-term debt$30.2M
Deferred revenue$9.59M
Total current liabilities$126.9M
Long-term debt$533.4M
Deferred revenue, non-current$0.00
Total non-current liabilities$1.43B
Capital lease obligations$332M
Total liabilities$1.55B
Common stock$0.00
Retained earnings-$-912.12M
Accumulated other comprehensive income (loss)$0.00
Total equity$1.14B
Total investments$0.00
Total debt$563.6M
Net debt$308.1M
Cash flow statement
2025
Net income-$-122.25M
Depreciation and amortization$173.4M
Stock-based compensation$20.5M
Change in working capital$188.2M
Accounts receivable-$-3.72M
Inventory-$-10.93M
Accounts payable-$-11.26M
Net cash provided by operating activities$272.8M
Investments in property, plant and equipment-$-44.19M
Acquisitions, net$0.00
Net cash used for investing activities$13.5M
Common stock issued$140M
Common stock repurchased$0.00
Dividends paid$0.00
Net cash used for financing activities-$-270.5M
Net change in cash$15.8M
Cash at end of period$255.5M
Operating cash flow$272.8M
Capital expenditure-$-60.51M
Free cash flow$212.3M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Trulieve Cannabis Corp.

        Trulieve Cannabis Corp. engages in the cultivation, processing, manufacturing, and retail distribution of medical and adult-use cannabis products. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. The company was founded by Kim Rivers & Jason Pernell on September 17, 1940 and is headquartered in Tallahassee, FL.

        CEO
        Kimberly A. Rivers
        Employees
        5K
        Beta
        1.66

        Explore

        Frequently asked questions

        What is the intrinsic value of Trulieve Cannabis Corp. (TRLV)?

        InvestorsCraft does not currently publish an intrinsic value for TRLV. How the IC value is calculated.

        Is TRLV undervalued?

        InvestorsCraft does not publish an undervaluation signal for TRLV at this time.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.